← Eichor
Study identifier: NCT07704671 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Individual Patient Data Meta-Analysis of Prospective Studies of Patients Treated With the GORE® Iliac Branched Endoprosthesis

Condition: Aneurysm  ·  Sponsor: Rijnstate Hospital

PhaseN/A
Planned participants1200
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Most studies investigating the outcomes of the iliac branched endoprosthesis (IBE) are of relatively small sample sizes. This individual patient data (IPD) analysis is a retrospective analysis of all available individual patient data on treatments of aorto-iliac with the Gore Iliac Branch Endoprosthesis device from previous peer reviewed publications. Corresponding authors and/or sponsors of the trials will be contacted to share the databases if available and to coauthor the publication. Th purpose of the IPD is to gain more robust evidence on the technical and clinical outcomes of the Gore IBE device using the individual patient data from as much publications as possible and to provide a sample size to perform meaningful subgroup analysis on the various outcome parameters.

This description comes directly from the study's public registry record.

Talk to the study team

Suzanne Holewijn, PhD  ·  0031 88 0057282  ·  vascularsurgery@rijnstate.nl

Always discuss trial participation with your own doctor first.

Locations (1)

RijnstateArnhem, Gelderland, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07704671